Pat McGrath Labs
What Can You Demonstrate That No One Else Can?
Prestige beauty closed 2025 at $36 billion, up 4 percent. Mass grew 5 percent to $72.7 billion. Full Q1 2026 data is not yet available.
In this issue
The Quarter in Brand Authority
The Brand Worth Watching — Pat McGrath Labs
The Vocabulary Shift
Category Signals
The Blind Spot
The Question
The prestige fragrance market grew 6 percent in the first half of 2025 while mass fragrance grew 17. That gap is not a pricing story. It is an authority story. The brands driving mass fragrance growth are offering consumers something they used to have to pay prestige prices for: a scent with a specific emotional register, a name that feels considered, packaging that does not embarrass you on a bathroom shelf. The prestige brands holding share are the ones whose authority was never about the price point in the first place.
Olaplex spent 2025 trying to add something it never needed when its science was working: an emotional territory. The Designed to Defy campaign, the Bond House pop-up in New York, the new visual identity, the updated website. A brand that built genuine clinical authority and then lost consumer trust to a lawsuit it won does not recover by building emotional resonance. It recovers by making the science impossible to ignore again.
Byredo enters 2026 in its first full year without Ben Gorham, and the copy on its About page has already answered the question this publication has been tracking since Q1 2024. The current About page describes Byredo as a brand that builds a living library of collective memories and cultural references. That is not a brand statement. It is a category description. Puig has the brand. They do not have the biography.
Rhode closed its first year inside e.l.f. Beauty doing what the acquisition required: expanding distribution, entering Sephora, growing the channel footprint. Rhode was a tight edit, a specific aesthetic, a founder whose skin was the demonstration. Its authority came from restraint. E.l.f.'s stated purpose is to make the best of prestige accessible, which is the opposite operating principle. Those two things have not collided yet. They will.
Clean beauty is no longer a positioning. It is a category entry requirement. What was differentiation in 2015 is table stakes in 2026. What comes after clean is the question. The brands that answer it first will own the next decade of the category the way the clean pioneers owned the last one.
Pat McGrath is the most credentialed makeup artist in the history of the industry. Not by reputation alone. By documented evidence: thirty-plus years of runway work for Prada, Versace, Louis Vuitton, and Maison Margiela; a DBE from the British Crown; a Louis Vuitton creative director appointment for La Beauté that launched in August 2025. The professional authority was never in question. What Pat McGrath Labs demonstrates is that professional authority, translated into a consumer brand, requires a product architecture that can sustain it. And that is where the brand failed.
Pat McGrath Labs launched in 2015 with the Gold 001 metallic eyeshadow kit, a small-batch product drop tied to a specific runway moment. The founding premise was exactly right: take what was happening backstage and bring it to the consumer directly. A 2018 investment from Eurazeo at a $1 billion valuation confirmed what the market believed: this was the most authoritative color brand in prestige beauty.
What happened between 2018 and 2026 is the clearest case study the category has produced on the gap between brand authority and brand architecture. The range expanded into Sephora and the small-batch, runway-tethered positioning that made the brand covetable became structurally incompatible with the volume a Sephora shelf requires. Eyeshadow is a shelf-stable category. Consumers do not repurchase palettes at $128 the way they repurchase foundation or serum. The brand lacked the replenishment categories that sustain prestige color at scale—the lipstick franchise, the base product, the everyday item that keeps a consumer in the brand between the moments she reaches for a Mothership palette.
By 2021 Eurazeo had quietly exited its stake. By 2024 Sienna Investment Managers had marked down its investment by 88 percent. Sales had declined to approximately $50 million annually. By October a lender had declared default and begun an asset auction process. On January 22, 2026, Pat McGrath filed for Chapter 11 to halt the auction, pledging $1 million of her own funds to pay vendors and employees.
GDA Luma Capital committed $30 million in new financing and will hold a 65 percent equity stake upon exit from bankruptcy. Pat McGrath transitions from CEO to chief creative officer. The brand will continue operating. Whether it continues as the same brand is the open question.
The diagnostic gap is specific: Pat McGrath Labs built the highest editorial authority in prestige color and then built a product architecture that could not hold it at commercial scale. The authority was real. The structure was not. What the brand does in the hands of GDA Luma will tell the category something it needs to know about whether institutional capital can hold editorial authority without the specific person who generated it.
Something is leaving the prestige category and a word is going with it: legacy.
Fewer than a quarter of prestige consumers now rank it as a purchase driver. More than 80 percent say scientific proof influences their choices. Brands that have spent a decade building authority through archive, founding dates, and generational continuity are holding an asset the consumer has quietly decided is worth less than they thought. That does not mean heritage is finished. It means heritage alone is not enough anymore.
What the consumer wants instead is proof. Not innovation, not breakthrough—those are claims. Proof is a demonstration. The clinical testing. The percentage improvement. The before and after that holds up. The prestige consumer has become rational. Efficacy and price outranked legacy by a wide margin. The story still matters. But it needs something under it now. The story earns attention. The proof earns trust.
Skincare, fragrance, color cosmetics, hair, and wellness signals tracked across observation, validation, and forecast.
Skincare—Proof Architecture Is the Price of Entry
Prestige skincare grew 3 percent for full-year 2025 despite a soft H1. The recovery was led by brands with named clinical mechanisms—Augustinus Bader, BIOEFFECT, Medik8—in a category where masstige alternatives now speak the same functional language at lower prices. Validation: Circana’s full-year 2025 report named skincare as the fastest-growing prestige category by units sold. Only 14 percent of beauty buyers believe higher prices indicate better quality. Forecast: the brands that cannot answer better than what, specifically? will continue losing ground to masstige alternatives that can.
Fragrance—Identity Premium Separating from Volume
Prestige fragrance grew 5 percent for full-year 2025, completing its normalization from double-digit growth. Luxury brands within prestige continued to grow double digits. Mass fragrance grew 15 percent. Validation: in Q4 2025, fragrance was outpaced by makeup, skincare, and hair during the holiday period for the first time in three years. Forecast: the fragrance consumer is bifurcating permanently. Brands with specific olfactory identities and non-replicable creative briefs will hold the luxury premium. Brands that rode the volume wave without a point of view will face pressure from mass alternatives closing the sensory gap.
Color Cosmetics—What the Pat McGrath Labs Bankruptcy Confirms
Prestige makeup grew 4 percent for full-year 2025. The category’s most significant event was not a launch—it was a bankruptcy. Pat McGrath Labs’ Chapter 11 filing confirms what the skinification thesis has been building toward since 2023: editorial authority without a replenishment architecture is not a sustainable commercial position in prestige color. Validation: Circana named skinification as the primary driver of makeup growth for the full year. Forecast: 2026 will separate the prestige color brands that built functional premises from the ones that built editorial ones.
Hair—Treatment and Professional Authority Define the Category
Hair led all prestige categories for full-year 2025 by dollar growth. Scalp care completed its third consecutive year of double-digit growth. Treatment launches were up over 20 percent. Validation: Olaplex’s professional channel grew 5.5 percent for the full year after multi-year decline, while specialty retail fell 8.3 percent. Forecast: the consumer trusts what professionals use. That trust is not available for purchase through distribution alone.
Wellness—Longevity Reaches Mainstream
Circana named wellness explicitly as a primary 2026 growth driver. Longevity skincare is now at Sephora. Brands with biomarker claims and documented cellular outcomes are generating consumer and investor attention simultaneously. Validation: Euromonitor’s 2025 Beauty Survey found 45 percent of luxury beauty shoppers are influenced by medical professionals when choosing products. Forecast: longevity skincare reaches peak mainstream adoption in 2026 to 2027.
The category has spent the past 18 months analyzing Drunk Elephant's decline through the lens of a brand that lost its core consumer to a younger one. That is accurate but incomplete.
Every investor who wrote a check for a founder-credentialed prestige beauty brand in the last five years used a valuation model that treated the founder’s authority as an acquirable asset. The Pat McGrath Labs bankruptcy is the clearest evidence yet that this model is wrong. Editorial authority—the specific kind that Pat McGrath built across thirty years on runway—is not an asset that transfers to a balance sheet. It is a personal attribute that exists in a specific person’s eye, reputation, and continued active presence. When Eurazeo invested at a $1 billion valuation in 2018, they were pricing something that could not be owned, only borrowed for as long as the person who generated it remained central to the brand. The trade is covering the bankruptcy as a story about debt and mismanagement. The more important story—the one that has implications for every acquisition in this category—is that the valuation methodology itself was flawed. The category has not yet named this. The next time a PE firm presents a DCF for a founder-credentialed prestige brand, the Pat McGrath Labs outcome should be in the denominator. It is not yet.
Pat McGrath Labs had the most defensible editorial authority in prestige color and could not convert it into a business that survives without emergency financing.
Your brand has authority too—of some kind, at some level, earned through something specific. The question is not whether you have it. The question is whether the product architecture you have built can capture and hold consumer spending between the moments that authority is most visible.
What is the everyday product in your range—the one a consumer repurchases without a reason, the one that keeps her in the brand when she is not reaching for your most exceptional thing? If you cannot name it, the Pat McGrath Labs story is not a cautionary tale about someone else.